Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
GMRE Global Medical REIT Inc
- 7.730
- -0.290-3.62%
Close Apr 4 16:00 ET
- 7.750
- +0.020+0.26%
Post 20:01 ET
516.97MMarket Cap773.00P/E (TTM)
7.970High7.550Low895.90KVolume7.940Open8.020Pre Close6.91MTurnover1.42%Turnover Ratio773.00P/E (Static)66.88MShares9.73152wk High1.13P/B487.79MFloat Cap7.15352wk Low0.84Dividend TTM63.10MShs Float203.756Historical High10.87%Div YieldTTM5.24%Amplitude1.146Historical Low7.708Avg Price1Lot Size
Global Medical REIT Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.79%138.41M | 6.14%34.95M | -3.70%34.18M | -5.79%34.21M | -3.12%35.07M | 2.75%140.93M | -9.26%32.93M | 0.40%35.49M | 7.83%36.32M | 13.65%36.2M |
| Operating revenue | -1.79%138.41M | 6.14%34.95M | -3.70%34.18M | -5.79%34.21M | -3.12%35.07M | 2.75%140.93M | -9.26%32.93M | 0.40%35.49M | 7.83%36.32M | 13.65%36.2M |
| Cost of revenue | 4.16%29.25M | 18.09%7.2M | 2.85%7.44M | 0.18%7.24M | -2.02%7.38M | 11.49%28.08M | -14.64%6.09M | 8.26%7.23M | 20.38%7.22M | 40.28%7.54M |
| Gross profit | -3.27%109.16M | 3.42%27.76M | -5.37%26.74M | -7.27%26.98M | -3.41%27.69M | 0.78%112.85M | -7.94%26.84M | -1.44%28.26M | 5.11%29.09M | 8.24%28.66M |
| Operating expense | 1.99%76.48M | 15.60%21.35M | -2.90%18.02M | -3.56%18.58M | -0.87%18.53M | 2.35%74.99M | -3.55%18.47M | 1.01%18.56M | 4.87%19.27M | 7.58%18.69M |
| Selling and administrative expenses | 25.34%21.12M | 82.63%7.71M | 0.32%4.38M | 2.85%4.59M | 16.88%4.45M | 1.86%16.85M | 4.17%4.22M | 10.25%4.37M | 2.91%4.46M | -9.36%3.8M |
| -General and administrative expense | 25.34%21.12M | 82.63%7.71M | 0.32%4.38M | 2.85%4.59M | 16.88%4.45M | 1.86%16.85M | 4.17%4.22M | 10.25%4.37M | 2.91%4.46M | -9.36%3.8M |
| Depreciation amortization depletion | -4.78%55.36M | -4.25%13.64M | -3.90%13.64M | -5.48%13.99M | -5.41%14.08M | 2.49%58.14M | -5.62%14.25M | -1.53%14.2M | 5.48%14.81M | 12.98%14.89M |
| -Depreciation and amortization | -4.78%55.36M | -4.25%13.64M | -3.90%13.64M | -5.48%13.99M | -5.41%14.08M | 2.49%58.14M | -5.62%14.25M | -1.53%14.2M | 5.48%14.81M | 12.98%14.89M |
| Operating profit | -13.70%32.68M | -23.43%6.41M | -10.10%8.72M | -14.56%8.4M | -8.17%9.16M | -2.19%37.86M | -16.34%8.37M | -5.81%9.69M | 5.59%9.83M | 9.51%9.97M |
| Net non-operating interest income expense | 7.13%-28.69M | -8.39%-7.57M | -0.92%-7.24M | 17.43%-6.99M | 16.70%-6.89M | -22.45%-30.89M | 13.39%-6.98M | -2.97%-7.17M | -56.79%-8.47M | -72.28%-8.27M |
| Non-operating interest expense | -7.13%28.69M | 8.39%7.57M | 0.92%7.24M | -17.43%6.99M | -16.70%6.89M | 22.45%30.89M | -13.39%6.98M | 2.97%7.17M | 56.79%8.47M | 72.28%8.27M |
| Other net income (expense) | -81.68%2.7M | 589.02%4.1M | -17.19%1.91M | -126.18%-3.36M | -89.66%49K | 126.60%14.76M | -772.92%-838K | -65.54%2.31M | 17,902.78%12.82M | 2,888.24%474K |
| Gain on sale of security | -72.98%4.21M | --5.77M | -20.36%1.82M | -126.46%-3.38M | ---- | 130.42%15.56M | --0 | -66.10%2.29M | --12.79M | --485K |
| Earnings from equity interest | ---20K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Special income (charges) | -102.96%-1.85M | -113.25%-1.85M | --0 | --0 | --0 | -157.63%-912K | -675.00%-868K | --0 | 97.78%-2K | -5.00%-42K |
| -Less：Restructuring and merger&acquisition | 252.27%155K | --155K | --0 | --0 | --0 | -87.57%44K | --0 | --0 | -97.78%2K | 5.00%42K |
| -Less:Impairment of capital assets | --1.7M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --868K | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 221.74%370K | 580.00%204K | 345.00%89K | -20.59%27K | 58.06%49K | -0.86%115K | 87.50%30K | -66.10%20K | 88.89%34K | 34.78%31K |
| Income before tax | -69.21%6.69M | 433.39%2.94M | -29.84%3.39M | -113.77%-1.95M | 6.49%2.31M | 8.69%21.73M | -70.18%551K | -51.81%4.83M | 269.77%14.18M | -49.30%2.17M |
| Income tax | ||||||||||
| Net income | -69.21%6.69M | 433.39%2.94M | -29.84%3.39M | -113.77%-1.95M | 6.49%2.31M | 8.69%21.73M | -70.18%551K | -51.81%4.83M | 269.77%14.18M | -49.30%2.17M |
| Net income continuous Operations | -69.21%6.69M | 433.39%2.94M | -29.84%3.39M | -113.77%-1.95M | 6.49%2.31M | 8.69%21.73M | -70.18%551K | -51.81%4.83M | 269.77%14.18M | -49.30%2.17M |
| Minority interest income | -94.74%59K | 267.69%109K | -39.58%145K | -128.82%-260K | 44.44%65K | 31.38%1.12M | -370.83%-65K | -53.58%240K | 530.77%902K | -73.53%45K |
| Net income attributable to the parent company | -67.82%6.63M | 359.42%2.83M | -29.33%3.25M | -112.75%-1.69M | 5.69%2.25M | 7.68%20.61M | -66.23%616K | -51.71%4.59M | 259.66%13.28M | -48.30%2.13M |
| Preferred stock dividends | 0.00%5.82M | 0.00%1.46M | 0.00%1.46M | 0.00%1.46M | 0.00%1.46M | 0.00%5.82M | 0.00%1.46M | 0.00%1.46M | 0.00%1.46M | 0.00%1.46M |
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -94.52%811K | 263.57%1.37M | -42.93%1.79M | -126.62%-3.15M | 17.98%794K | 11.04%14.79M | -328.26%-840K | -61.05%3.14M | 428.62%11.82M | -74.71%673K |
| Basic earnings per share | -95.65%0.01 | 300.00%0.02 | -40.00%0.03 | -127.78%-0.05 | 0.00%0.01 | 15.00%0.23 | -200.00%-0.01 | -58.33%0.05 | 500.00%0.18 | -75.00%0.01 |
| Diluted earnings per share | -95.65%0.01 | 300.00%0.02 | -40.00%0.03 | -127.78%-0.05 | 0.00%0.01 | 15.00%0.23 | -200.00%-0.01 | -58.33%0.05 | 500.00%0.18 | -75.00%0.01 |
| Dividend per share | 0.00%0.84 | 0.00%0.21 | 0.00%0.21 | 0.00%0.21 | 0.00%0.21 | 0.00%0.84 | 0.00%0.21 | 0.00%0.21 | 0.00%0.21 | 0.00%0.21 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
